Leerink Partners Upgrades Halozyme Therapeutics (HALO) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 110.42 +0.58 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $109.84 | 52 Week High | $18.39 | |||
| Open | $109.70 | 52 Week Low | $6.96 | |||
| Day High | $112.65 | P/E | N/A | |||
| Day Low | $109.70 | EPS | $-0.58 | |||
| Volume | 1,845,335 | |||||
